関連する実験動画
Updated: May 11, 2026

10:31
Antigenic Liposomes for Generation of Disease-specific Antibodies
Published on: October 25, 2018
12.5K
小児の鶏卵アレルギーに対する非常に低用量導入によるより安全な経口免疫療法
Fumi Ishikawa1, Yumiko Miyaji1, Kiwako Yamamoto-Hanada1
1Allergy Center, National Center for Child Health and Development, Tokyo, Japan.
The journal of allergy and clinical immunology. Global
|September 2, 2025
まとめ
標準的なOITと比較して,非常に低い初期用量を用いた新しい経口免疫療法 (OIT) の安全性が向上し,鶏卵 (HE) アレルギーを持つ子供では有害事象が少なくなりました. このアプローチは,HEアレルギーに対するより安全な治療法である可能性があります.
科学分野:
- アレルギーと免疫学
- 小児アレルギー
- 免疫療法
背景:
- 小児における鶏卵アレルギーの経口免疫療法 (OIT) に重大な障害となっている.
- 治療の順守と結果を改善するために,より安全な OIT 方法が必要です.
研究 の 目的:
- HEアレルギーの子供に対する新しいOITプロトコルの安全性と有効性を評価する.
- 実験用療法 (ET) と標準療法 (ST) を比較する.
主な方法:
- 第II相,ダブルブラインド,ランダム化制御試験が行われました.
- HEアレルギーの被験者 (1~18歳) は,ET (非常に低い開始用量) またはST (固定維持用量) にランダムに分けられました.
- 主要安全性評価結果:最初のIgE媒介の即効性反応までの日数;有効性評価結果:累積許容量 (CTD) の変化.
主要な成果:
- 試験は早期に終了したが,ET群では最初の反応までの時間がかなり長かった (P=0. 033).
- ETグループでは副作用の発生率が低く,治療の順守が改善された可能性がある.
- CTDの変化で測定された有効性は,グループ間で比較できませんでした.
結論:
- OITは,HEアレルギーの子供にとって,非常に低い初期用量を用いることがより安全な方法であるようです.
- この方法は,治療の負担を軽減し,小児患者の耐性を改善します.
関連する概念動画
Vaccinations
Overview
Active versus Passive Immunity
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
Active Immunity
Active immunity refers to the resistance one develops...
Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

